Guidance for the evaluation and public health management of suspected outbreaks of meningococcal disease

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.)
• Description:
  Version 1.0, November 9, 2017
  
  This report summarizes updated CDC guidance for the evaluation and public health management of suspected outbreaks of meningococcal disease in the United States. Guidance was initially developed in 1997 and subsequently updated following the licensure of the quadrivalent meningococcal conjugate vaccine (MenACWY) and implementation of the routine MenACWY program [1-3]. In 2014, CDC issued interim guidance for the control of serogroup B meningococcal disease outbreaks in organizational settings prior to licensure of serogroup B meningococcal (MenB) vaccines in the United States [4].
  
  This guidance document replaces both the recommendations in Appendix B of the 2013 Advisory Committee on Immunization Practices (ACIP) statement “Prevention and Control of Meningococcal Disease” and the 2014 CDC document “Interim Guidance for Control of Serogroup B Meningococcal Disease Outbreaks in Organizational Settings” [3, 4].
  
  meningococcal-outbreak-guidance.pdf
  
  
• Subjects:
  Disease Outbreaks Meningococcal Infections Meningococcal Infections/prevention & Control Meningococcal Vaccines
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Guidance
• Pages in Document:
  20 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:69111f7fdbaa63bbab3f2f60747ab9b654ae174a396fc2f8221d0f8d8c23151a
• Download URL:
  https://stacks.cdc.gov/view/cdc/55358/cdc_55358_DS1.pdf
• File Type:
  [PDF - 198.11 KB ]